International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 4 : 2778-2783
Research Article
A Cross-Sectional Study on Knowledge Among Parents with Beta Thalassemia Major Children in Government District Hospital Kalaburagi
 ,
 ,
 ,
Received
June 14, 2026
Accepted
July 17, 2026
Published
July 27, 2026
Abstract

Background: Thalassemia is a public health problem worldwide. With the high disease burden of thalassemia, low socioeconomic conditions and poor preventive strategies, our patients are left with no other option except the repeated blood transfusion. So prevention is the only tool to reduce the burden of this disease. This study was done to identify the gap in knowledge, attitude and practices (KAP) about β-thalassemia among the parents of beta thalassemia children. So that it will be helpful to reduce the burden of the disease in the society in the near future.

Objectives: To assess the Knowledge among parents with beta thalassemia major children regarding beta thalassemia major disease.

Materials and Methods: A semi structured pre-validated questionnaire designed to assess the Knowledge, Attitudes and Practices in relation to beta thalassemia major disease was administered to all the parents fulfilling the inclusion criteria. Collected data was analysed.

Results: In this study, None of the participants had knowledge about thalassemia before their first child was born. In this study, 76.9% study subjects knew and understood the genetic nature of Thalassemia. In our study, about 75.4% participants didn’t know about premarital screening and 50.8% didn’t know about prenatal diagnosis.

Conclusion: It was seen from our study that parents don’t have adequate knowledge about thalassemia major. Health education and periodic counselling of parents and care takers about prevention of thalassemia needs to be implemented at every thalassemia day care centre.

Keywords
INTRODUCTION

Beta thalassemia is one of the most common single-gene inherited condition in the world.1Thalassaemia major is an inherited blood disorder, which can be defined as "the inability of the human body to produce sufficient amount of hemoglobin in red blood cell" thus resulting in severe anaemia.2

 

Various studies show that around 70,000 infants are born with beta thalassemia worldwide every year, and 270 million people are carriers of haemoglobinopathies.3 Due to its high prevalence, Thalassemia is a public health problem worldwide, which is particularly common in the Mediterranean as well as in Southeast Asia, Africa and Middle East1 with reported rates ranging from 2 to 25%.4

 

With the high disease burden of thalassemia, low socioeconomic conditions and poor preventive strategies, our patients are left with no other option except the repeated blood transfusion, which inadvertently results in high chances of infections like hepatitis B and C, iron overload and other immunological responses.5 This affects the patient’s physical, emotional and school functioning leading to an impaired quality of life and also causes tremendous financial burden to their families.6

 

The definitive cure of thalassemia is bone marrow  transplant, this facility is available only in very few centers in India. So prevention is the only way to reduce the burden of disease in thalassemia. The main prevention strategies comprise of providing appropriate information to the public and professionals, screening and counseling of families at risk and screening of couple prior to marriage.7

 

The Policy For Prevention and Control of Hemoglobinopathies –Thalassemia, Sickle Cell Disease and variant Hemoglobins in India (by Ministry of Health and Family Welfare), 2018, encompasses the vision to enable access to affordable and quality care to all patients with Thalassemia, HbE and Sickle Cell Disease, and also to lower the prevalence of hemoglobinopathies through awareness and screening programs.8

 

The purpose of this study is to assess the awareness about thalassemia major disease among parents with thalassemia children and to identify the gap in knowledge about β-thalassemia among the parents of beta thalassemia children. So that it will be helpful to reduce the burden of the disease in the society in the near future.

 

MATERIALS AND METHODS

This cross sectional descriptive study was conducted over a period of 3 months (from  July 2023 to September 2023)  among  65 parents of beta thalassemia major children attending department of Pediatrics, Gulbarga institute of Medical sciences, Kalaburagi .The study was conducted after obtaining the ethics committee approval from Institutional Ethics committee. Informed consent was obtained from all eligible participants after explaining the objectives and nature of this study in their own language. A semi structured pre-validated questionnaire designed to assess the Knowledge in relation to beta thalassemia major disease was administered to all the parents fulfilling the inclusion criteria. The data collected through this questionnaire includes: socio demographic details of parents and children and various information to assess the knowledge of parents with respect to thalassemia major disease like, about nature of the disease, about premarital screening, prenatal diagnosis, genetic counseling, iron chelation therapy and importance of  hepatitis B vaccination.

 

Statistical data was analyzed by using statistical package for social sciences (SPSS, version 25.0). If p value is <0.05, it is considered as statistically significant.

 

RESULTS

Table 1: Socio Demographic profile of study participants

Variables

Categories

No. of participants

Percentage

 
 

Age of participant 

20—30 years

27

41.5

 

31—40 years

31

47.7

 

41—50 years

7

10.8

 

Mean ± SD

33.84 ± 7.54

----

 

Gender of participant

Male

36

55.4

 

Female

29

44.6

 

Area of residence

Urban area

20

30.8

 

Rural area

45

69.2

 

Religion/ caste

Muslims

6

9.2

 

General

6

9.2

 

OBC

18

27.7

 

SC/ST

35

53.9

 

Socio-economic status

(B G Prasad classification) 9

Upper Class

0

0.0

 

Upper Middle Class

0

0

 

Middle Class

3

4.5

 

Lower Middle Class

24

37.0

 

Lower Class

38

58.5

 

Educational status of participant  

Illiterate

22

33.8

 

Primary

13

20.0

 

Secondary and degree

30

46.2

 

Occupation of participant 

House wife

23

35.4

 

Daily wage worker

38

58.4

 

Employed

4

6.1

 

 

In the study, the mean age of participants was 33.84 years. Majority of participants 31 (47.7%) were belonging to the age group of 31 to 40 years, The male (father) participants were 36 (55.4%) and female (mother) participants were 29 (44.6%). Majority of participants 45 (69.2%) residential area was rural.

 

Majority of participants 38 (58.5%) were belonging to the socio-economic status of lower class, followed by 24 (37.0%) were belonging to lower middle class and 3 (4.5%) of the participants were belonging to middle class, no participants were seen in upper middle class and upper class.  

 

Out of 65 participants; 22 (33.8%) participants were illiterate, 13 (20.0%) had primary education and 30 (46.2%) had secondary and degree education. Majority of participants 38 (58.4%) were daily wage workers.

 

Table 2: Knowledge of participants regarding Thalassemia major

SL No

 Survey questions related to knowledge

Answer

No.

%

1

 Were you aware of thalassemia before the birth of your first child?

No

65

100.0

Yes

0

0.0

2

What kind of disease is thalassemia?

Don’t know

15

23.1

A genetic/Inherited disorder

50

76.9

Infectious disease

0

0.0

Any other

0

0.0

3

Which of the following do you know to be a cause or risk factors for thalassemia?

Don’t know

46

70.0

Positive Family history

19

29.2

Poor health at birth

0

0.0

Any other

0

0.0

4

Do you know the role of consanguinity in thalassemia?

Don’t know

34

52.3

Not necessary

17

26.2

Yes

14

21.5

5

Which  treatment options for thalassemia are you aware of?

Don’t know

8

12.3

Blood transfusion

28

43.1

Blood transfusion and bone marrow transplant

29

44.6

6

Are you aware of  prenatal diagnostic testing for thalassemia?

No

33

50.8

Yes

32

49.2

7

Are you aware of premarital screening for thalassemia?

No

49

75.4

Yes

16

24.6

8

Do you know that blood transfusion is needed to the patient throughout life?

No

 

0

0.0

Yes

65

100.0

9

Which of the following methods do you know can help prevent thalassemia?

Don’t know

33

50.8

Genetic counseling

15

23.1

Premarital screening

24

36.9

Prenatal diagnosis

30

46.1

10

Do you know about the risk of getting Hepatitis B because of repeated transfusion?

No

28

43.1

Yes

37

56.9

11

Do you know about Hepatitis B vaccine?

No

55

84.6

Yes

10

15.4

12

Are you aware that repeated blood transfusions can cause iron overload ?

No

 

28

43.1

Yes

37

56.9

13

Are you aware of Iron chelation therapy?

No

34

52.3

Yes

31

47.7

 

Table 2 shows Knowledge of participants regarding thalassemia. None of the participants had knowledge about thalassemia before their first child was born. when the participants are asked about cause of thalassemia, majority of them 50(76.9%) said that it is a genetic/Inherited disorder and 15(23.1%) said that they don’t know what causes thalassemia.

 

Fig 1: Participants knowledge with respect to treatment options for Thalassemia Major

 

when the participants were asked for treatment options of thalassemia, 29(44.6%) said both blood transfusion and bone marrow transplant,28(43.1%) said only Blood transfusion and 8(12.3%) did’nt know any of the treatment options for thalassemia. About 34(52.3%) participants didn’t know the role of consanguinity in thalassemia. 49(75.4%) didn’t know about premarital screening and 33(50.8%) didn’t know about prenatal diagnosis. All of them knew that blood transfusion is needed to the thalassemia major patient throughout life.

 

Majority of them 46(70.0%) didn’t know the reasons and risk factors of thalassemia and 19(29.2%) knew that Positive Family history is a risk factor for thalassemia.

 

About 28(43.1%) didn’t have any knowledge about iron overload because of repeated transfusions in thalassemia. About 34(52.3%) didn’t know about iron chelation therapy in thalassemia, About 28(43.1%) didn’t  know about the risk of getting Hepatitis B because of repeated  transfusion and 55(84.6%) didn’t know about Hepatitis B vaccine.

 

When the participants were asked about prevention methods of thalassemia, 33( 50.8% ) didn’t know any of the prevention methods,  15 ( 23.1%)  said genetic counseling, 24(36.9%) said premarital screening and  30(46.1%) of  them  said prenatal diagnosis as the methods to prevent thalassemia.

 

DISCUSSION

Thalassemia is a hereditary hemoglobinopathy and a chronic disorder so prevention of thalassemia is utmost important aspect to reduce the burden on society, for these social scientists, doctors and counselors should play a major role in prevention. Usually government hospital of tertiary level in all states are often over-crowded with these patients and  parents of these thalassemia patients needs  to be counseled and sustained motivation  to parents of children suffering from thalassemia is often needed. Doctors and counselors  should focus on  to serve these  people from  simple infections to long lasting chronic illnesses. Government should take initiation to give enough support in providing counselors for  these disorders.10

 

In our study, Majority of participants 31 (47.7%) were belonging to the age group of 31 to 40 years, The male (father) participants were 36 (55.4%) and female (mother) participants were 29 (44.6%). Majority of participants 45 (69.2%) residential area was rural. In the current study, we had a slight male preponderance of Thalassemia with 41(63.1%) males and 24(36.9%) females. A study by Goyal JP A et al, and Saxena A et al, showed a male preponderance similar to in this study.11,12 However, the study conducted in Pakistan by Arif F et al, showed a slight female preponderance.13

 

In this study, None of the participants had knowledge about thalassemia before their first child was born. In this study, 76.9% study subjects knew and understood the genetic nature of Thalassemia. This knowledge was better than that in the studies conducted  by Biswas B et al, (47.6%), Saxena A et al, (47.5%) but lesser than the study conducted by Arif F et al, (82%).12,13,14. Majority of them,70.0% didn’t know the  reasons and risk factors of thalassemia and 29.2% knew that Positive Family history is a risk factor for thalassemia.

 

In our study,44.6% of the participants knew that both blood transfusion and bone marrow transplant are the treatment options for thalassemia major,43.1%  knew only Blood transfusion as the treatment option ,12.3%  did’nt  know any of the treatment options for thalassemia. Where as in the studies conducted by Saxena A et al, 62.5% knew about the need of blood transfusion and  in the study conducted by  Biswas B et al, only 75.9%  knew. 12,14 About 52.3% participants didn’t know the role of consanguinity in thalassemia. In our study, about 75.4% participants didn’t know about premarital screening and 50.8% didn’t know about prenatal diagnosis. Where as in the study conducted  by Biswas B et al , 52.4% and 50.9% knew about premarital counseling and antenatal screening, respectively.14

 

 In our study, about 56.9% had knowledge about iron overload because of repeated transfusions in  thalassemia and 47.7%  knew about iron chelation therapy in thalassemia . In the study by Goyal JP et al, most of them knew about iron overload.11 comparatively better results were seen in the study conducted  by Kalraa RK et al where 100% knew about the reactions to the blood being transfused  and 100%  knew  that iron overload could be a potential complication of repeated transfusions and 100% subjects knew that iron chelation therapy is needed for the treatment. 15 About 56.9% knew about the risk of getting Hepatitis B because of repeated  transfusion and 15.4%  knew about Hepatitis B vaccine. Where as in the  study conducted  by Kalraa RK et al 100% subjects knew the importance of  hepatitis B vaccination  in chronically transfused  patients.15

 

From our study, it was found that, knowledge of the parents regarding the cause, course, complications ,management  and prevention of Thalassemia is not adequate. This emphasizes the need for such a social worker/counsellor to be associated with every Thalassemia day care center so that  it helps in creating awareness regarding this disease in the parents.

 

CONCLUSION

It was seen from our study that parents don’t have adequate knowledge related to thalassemia major disease prevention and treatment; Health education and periodic counseling of parents and care takers about prevention of thalassemia needs to be implemented at every thalassemia day care centre. Dedicated social worker/counsellor should be associated with every thalassemia day care centre to counsell the parents and care takers of thalassemia major. And it is better to have a child psychologist in the thalassemia day care centre to take care of mental health of thalassemia major children.

 

ACKNOWLEDGEMENT

Authors acknowledge the help received from scholars whose articles have been cited and included in references of this manuscript.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: The study was approved by the Institutional Ethics Committee.

 

REFERENCES

  1. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for beta-thalassaemia: a review of international practice. Eur J Hum Genet. 2010; 18:1077-83.
  2. Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH. Screening and counseling for thalassemia. Blood. 2006; 107:1735-7.
  3. Aabolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29:233-8.
  4. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, et al. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001; 25:285-96.
  5. Dehkordi AH, Heydarnejad MS. Effect of booklet and combined method on parent’s awareness of children with beta-thalassemia major disorder. J Pak Med Assoc. 2008; 58(9):485-7.
  6. Aggarwal K. A Study to assess the Knowledge of Parents of thalassemic Children in the age group of 2-7 years attending thalassemic Ward of a Selected Hospital of Delhi, regarding management of thalassemia. Int J Nurs Midwifery Res. 2016;3(1):36-40.
  7. Bryan S, Dormandy E, Roberts T, Ades A, Barton P, Juarez-Garcia A, et al. Screening for sickle cell and thalassaemia in primary care: A cost-effectiveness study. Br J Gen Pract.2011; 61:591.
  8. Verma IC, Ghosh K, Colah R, Gatpylee AK. The Policy For Prevention and Control of Hemoglobinopathies –Thalassemia, Sickle Cell Disease and variant Hemoglobins in India. Ministry of Health and family welfare. New Delhi. 2018. Available at: https://mohfw.gov.in/sites/default/files/drft%20policy.pdf. Accessed 5 April 2024.
  9. Mangal A, Kumar V, Panesar S, Talwar R, Raut D, Singh S. Updated BG Prasad socioeconomic classification, 2014: A commentary. Indian J Public Health 2015;59:42-4.
  10. Bandyopadhyay B, Nandi S, Mitra K, Mandal PK, Mukhopadhyay S, Biswas AB. A Comparative study on perceptions and practices among parents of thalassemia children attending two different institutions. Indian Journal of Community Medicine. 2003; 28(3):128-132.
  11. Goyal JP, Hpapani PT, Gagiya H. Awareness among parents of children with thalassemia major from Western India. Int J Med Sci Public Health. 2015;4(10):1356-60.
  12. Saxena A, Sharif M, Siddiqui S, Singh S. Knowledge practice and experiences of parents with a thalassemic child. Int J Contemp Pediatr. 2017;4(5):1630-3.
  13. Arif F, Fayyaz J, Hamid A. Awareness among parents of children with thalassemia major. J Pak Med Assoc. 2008;58(11):621-4.
  14. Biswas B, Naskar NN, Basu R, Dasgupta A, Paul B, Basu K. Knowledge of the caregivers of thalassemic children regarding thalassemia: A cross-sectional study in a tertiary care health facility of eastern India. Iraqi J Hematol. 2018;7(2):49.
  15. Kalra RK, Kaur D, Sodhi M, Kaur J. Knowlegde, attitude and practice in parents of chronically transfused thalassemic patients regarding thalassemia in thalassemia day care unit in government medical college, Amritsar, Punjab, India. Int J Contemp Pediatr 2019;6:2469-75.
Recommended Articles
Research Article Open Access
Effect of Monotherapy and Multiple Topical Antiglaucoma Drug Therapy on Tear Film Stability and Tear Secretion
2026, Volume-7, Issue 4 : 2798-2803
Research Article Open Access
Impact of Topical Antiglaucoma Medications on Tear Film Stability and Tear Secretion in Glaucoma Patients
2026, Volume-7, Issue 4 : 2804-2810
Research Article Open Access
A STUDY ON ATTITUDE AMONG PARENTS WITH BETA THALASSEMIA MAJOR CHILDREN IN GOVERNMENT DISTRICT HOSPITAL KALABURAGI
2026, Volume-7, Issue 4 : 2774-2777
Research Article Open Access
A Cross-Sectional Study on Practice Among Parents with Beta Thalassemia Major Children in Government District Hospital Kalaburagi
2026, Volume-7, Issue 4 : 2769-2773
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 4
Citations
4 Views
6 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved